Bacterial meningitis is a devastating infectious disease because, even when cured, most survivors live with permanent neurological disabilities such as motor impairment, cognitive delay, hearing and vision loss, seizures, and psychiatric disorders, due to neuronal damage caused by the infection. Researchers at Karolinska Institutet have now revealed new insights into the mechanisms of bacterial brain invasion and neuronal damage during bacterial meningitis.
The bacterium Streptococcus pneumoniae (the pneumococcus) is the primary cause of meningitis globally. The pneumococcus produces and releases pneumolysin (PLY), which is one of the major weapons used by the bacteria to damage cells.
Photo: Encephalitis International
One single amino acid substitution in pneumolysin
“We discovered that Streptococcus pneumoniae, isolated from meningitis patients, release a variant of PLY which differs from only one single amino acid compared to the NCBI PLY-reference Streptococcus pneumoniae laboratory strain D39. This single amino acid substitution significantly enhances the capability of PLY to damage neurons,” says , PhD student in Federico Iovino’s research group at the Department of Neuroscience and first author of the study.
“We shed light into how one single amino acid substitution can dramatically affect the toxic power of PLY”, says , Associate Professor and research group leader at the Department of Neuroscience.
This study is the result of a fantastic collaborative work with Prof. ‘s research group at the same department, who performed the electrophysiological recording experiments, as well as collaborators from the University of Greifswald (Germany) and Loyola Chicago University (USA), who helped in the pneumolysin gene sequence, amino acid sequence and protein structure analysis.
This study was published in iScience, multidisciplinary open access journal of the Cell Press.
The brain invasion pattern of Streptococcus pneumoniae
Photo: Private
In a separate study, the researchers performed 3D whole brain imaging to determine the pattern of brain invasion by blood-borne Streptococcus pneumoniae.
“We have observed that all regions of the brain are equally affected by pneumococcal infection in an experimental meningitis in vivo model and, furthermore, that neurogenesis is severely affected during meningitis pathogenesis,” says , PhD student in Federico Iovino’s research group at the Department of Neuroscience and first author of this second study.
This study was performed in collaboration with Dr. and Prof. , both at the same department. The article was published in Neurobiology of Disease, top journal (Q1) in the category “Neurosciences”.
“The findings support the real scenario of meningitis in society, in fact the different brain regions, equally affected by bacterial invasion, control different body functions, and this corresponds to the incredible variety of neurological sequelae experienced by meningitis survivors”, says Federico Iovino, last author and principal investigator of the study.
Importance of research findings
Each year there are approximately 2,5 million cases of bacterial meningitis globally, and most of them caused by Streptococcus pneumoniae. It is therefore plausible to hypothesize that new variants of PLY with different cytotoxic capabilities towards neurons are still out there to be discovered.
The finding that Streptococcus pneumoniae can invade all brain regions is a fundamental piece of knowledge that highlights the need of finding new therapeutic approaches to protect neurons in all brain regions from bacterial interaction, and from PLY exposure.
“PLY, with its incredible capabilities to injure neurons and disrupt neuronal activity, has a major role in the onset of neurological disabilities experienced by up to 70 percent of meningitis survivors. Our goal is to understand bacterial interactions with brain cells to develop new approaches to block such interactions and protect the brain from bacterial infections” says Federico Iovino.
Funding
Both studies were supported through Federico Iovino’s funding from Karolinska Institutet, The Swedish Research Council (Vetenskapsrådet), Bjarne Ahlström Memorial Fund, the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Wera Ekström Fund for Pediatric Research, Magnus Bergvall Foundation, Tore Nilson Foundation, Åhlén Foundation, and Gun & Bertil Stohne Foundation.
Publications
Serra S, Iannotti V, Ferrante M, Tofiño-Vian M, Baxendale J, Silberberg G, Kohler T.P, Hammerschmidt S, Ulijasz A.T , Iovino F
iScience,
Farmen K, Tofiño-Vian M, Wellfelt K, Olson L, Iovino F
Neurobiol Dis 2024 Apr;195():106484
